Reprint

Carbohydrate-Based Drugs Discovery

Edited by
March 2024
312 pages
  • ISBN978-3-7258-0432-0 (Hardback)
  • ISBN978-3-7258-0431-3 (PDF)

This book is a reprint of the Special Issue Carbohydrate-Based Drugs Discovery that was published in

Chemistry & Materials Science
Medicine & Pharmacology
Summary

Carbohydrates play an essential role in the organism and have many bioactivities. Carbohydrate-based drug discovery is an up-and-coming area of research in medicinal chemistry. Bioactive carbohydrates open up a new source for drug development. More than 170 carbohydrate-based drugs have been successfully approved as anticoagulants, antitumor agents, antidiabetic agents, antibiotics, antiviral agents, and vaccines. However, most carbohydrates have low druggability. As such, new methods and strategies to improve carbohydrates’ druggability are in high demand.This Special Issue aimed to serve as an open forum where researchers can share their experiences and findings on carbohydrate-based drugs, with a focus on the discovery and development of new carbohydrate-based therapeutic agents. Contributions to this issue, in the form of both original research and review articles, cover the separation, identification, synthesis, and pharmacology of bioactive carbohydrates, including monosaccharides, oligosaccharides, polysaccharides, glycopeptides, glycoproteins, glycomimetics, and others.

Format
  • Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
hepatocellular carcinoma; metastasis; ASGPR; gene therapy; VEGF/VEGFR2 signaling pathway; breastfeeding women; saliva; sialic acids (Sia); avian influenza virus (AIV); glycoprotein; resin glycosides; macrocyclic natural glycolipids; ring-opened analogues; cytotoxicity; protein translocation; Sec61 translocon; molecular docking; LFG-Na; sea cucumber; Holothuria fuscopunctata; molecular weight; HPSEC-MALLS-RID; bioactivity assay; quality control; rhamnose; deoxythymidinediphosphate-L-rhamnose; guanosine diphosphate rhamnose; uridine diphosphate-rhamnose; rhamnosyltransferase; rhamnose biosynthesis; iminosugar; pyrrolidine; multivalent effect; glucosidase inhibitors; osteoarthritis; hyaluronic acid; hyaluronic acid oligosaccharide derivatives; ATDC5; lipopolysaccharide; active ingredients; polysaccharide purification; glucan; mannan; immunomodulator; heparin; applications of heparin; challenges of heparin therapy; glycosylation; Ferrier rearrangement; perfluorinated solvent; high stereoselectivity; reusability; aryl-C-glycoside; novel structures; bioactivity; synthesis; antibiotic; aminoglycoside; structural modification; structure–activity relationship; functional oligosaccharides; gut microbiota; intestinal barriers; intestinal diseases; 2-deoxythioglycosides; glycosylation; silver triflate; stereoselective synthesis; glycals; anticancer; polysaccharides; drug delivery systems; nanomedicines; glycosylation; proteins; erythropoietin; monoclonal antibodies; amino alcohols; 3-aminosugars; sulfamidates; deprotection; Kukhtin–Ramirez reaction; tumor-associated carbohydrate antigens; KH-1; fluoro-modification; tumor vaccine